VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,268,111 | -30.5% | 927,562 | +1.7% | 0.00% | -33.3% |
| Q2 2023 | $14,778,462 | +416.6% | 911,688 | +430.6% | 0.00% | +200.0% |
| Q1 2023 | $2,860,803 | +140.1% | 171,820 | +35.5% | 0.00% | – |
| Q4 2022 | $1,191,751 | +245.4% | 126,782 | -0.0% | 0.00% | – |
| Q3 2022 | $345,000 | -5.7% | 126,796 | 0.0% | 0.00% | – |
| Q2 2022 | $366,000 | -81.2% | 126,796 | -80.5% | 0.00% | – |
| Q1 2022 | $1,947,000 | -50.6% | 648,871 | -24.4% | 0.00% | -100.0% |
| Q4 2021 | $3,945,000 | -35.5% | 857,774 | -11.9% | 0.00% | 0.0% |
| Q3 2021 | $6,114,000 | +2.1% | 973,507 | -2.6% | 0.00% | 0.0% |
| Q2 2021 | $5,988,000 | -5.4% | 999,801 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $6,330,000 | -16.7% | 1,000,844 | -25.9% | 0.00% | 0.0% |
| Q4 2020 | $7,601,000 | -5.9% | 1,350,166 | -2.7% | 0.00% | -50.0% |
| Q3 2020 | $8,076,000 | -21.4% | 1,387,545 | -2.6% | 0.00% | 0.0% |
| Q2 2020 | $10,274,000 | +174.3% | 1,424,968 | +78.0% | 0.00% | +100.0% |
| Q1 2020 | $3,746,000 | -42.9% | 800,582 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $6,555,000 | +14.9% | 817,385 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $5,704,000 | -10.6% | 829,101 | +7.8% | 0.00% | -50.0% |
| Q2 2019 | $6,381,000 | -15.2% | 768,866 | +1.6% | 0.00% | 0.0% |
| Q1 2019 | $7,524,000 | +34.9% | 756,950 | +3.8% | 0.00% | 0.0% |
| Q4 2018 | $5,576,000 | -48.0% | 728,958 | +18.5% | 0.00% | -33.3% |
| Q3 2018 | $10,713,000 | +129.0% | 614,963 | +24.8% | 0.00% | +200.0% |
| Q2 2018 | $4,678,000 | +1255.9% | 492,845 | +524.2% | 0.00% | – |
| Q1 2018 | $345,000 | +111.7% | 78,953 | +97.1% | 0.00% | – |
| Q4 2017 | $163,000 | +409.4% | 40,052 | +136.1% | 0.00% | – |
| Q3 2017 | $32,000 | +77.8% | 16,962 | 0.0% | 0.00% | – |
| Q2 2017 | $18,000 | -28.0% | 16,962 | 0.0% | 0.00% | – |
| Q1 2017 | $25,000 | +25.0% | 16,962 | 0.0% | 0.00% | – |
| Q4 2016 | $20,000 | -16.7% | 16,962 | 0.0% | 0.00% | – |
| Q3 2016 | $24,000 | +14.3% | 16,962 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | – | 16,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |